{"title":"Improving CVD risk assessment with eGFR","authors":"Sue Lyon","doi":"10.1002/fps.22","DOIUrl":null,"url":null,"abstract":"<p>A quiet revolution is taking place within the NHS as laboratories grad-ually switch from serum creatinine to estimated glomerular filtration rate (eGFR) as the prime measure of renal function. This change follows recommendations in the National Service Framework for Renal Services,1 but the move will have an impact far beyond the renal com-munity, affecting health profess-ionals and patients throughout primary and secondary care. Copyright © 2006 John Wiley & Sons, Ltd.</p>","PeriodicalId":100566,"journal":{"name":"Future Prescriber","volume":"7 1","pages":"26-28"},"PeriodicalIF":0.0000,"publicationDate":"2008-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/fps.22","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/fps.22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A quiet revolution is taking place within the NHS as laboratories grad-ually switch from serum creatinine to estimated glomerular filtration rate (eGFR) as the prime measure of renal function. This change follows recommendations in the National Service Framework for Renal Services,1 but the move will have an impact far beyond the renal com-munity, affecting health profess-ionals and patients throughout primary and secondary care. Copyright © 2006 John Wiley & Sons, Ltd.
用eGFR改善心血管疾病风险评估
随着实验室逐渐从血清肌酐转向肾小球滤过率(eGFR)作为肾功能的主要指标，NHS内部正在悄然发生一场革命。这一变化遵循了《国家肾脏服务框架》的建议，但此举的影响将远远超出肾脏社区，影响到初级和二级保健的卫生专业人员和患者。版权所有©2006 John Wiley &儿子,有限公司
本文章由计算机程序翻译，如有差异，请以英文原文为准。
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
